Huck et al. pointed out that although the expression of PRKD3 was not obvious in some breast cancer, it was significantly increased in highly aggressive triple negative breast cancer and negatively regulated by estrogen (Huck et al., 2014; Borges et al., 2015). Here, PRKD3 is linked to triple-negative breast carcinoma.